GRIFOLS | GRF - Equity Capital And Reserves



GRIFOLS reported EUR7.6B in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Alcon AG USD 22.13B 111M Jun/2025
Almirall EUR 1.46B 37.19M Jun/2025
Amadeus IT EUR 5.3B 198.3M Jun/2025
Amarin USD 473.69M 12.49M Mar/2025
argenx SE 6.1B 597.47M Jun/2025
AstraZeneca USD 44.72B 3.68B Jun/2025
Bayer EUR 30.5B 2.08B Jun/2025
Cie Automotive EUR 1.5B 96.05M Dec/2024
Demant DKK 9.4B 168M Jun/2025
Ence Energia y Celulosa EUR 650.7M 9.7M Sep/2024
Essilor EUR 37.82B 3.18B Jun/2025
Ferrovial EUR 6.08B 2.31B Dec/2024
Fresenius EUR 18.94B 465M Jun/2025
Fresenius Medical Care EUR 14.33B 1.18B Jun/2025
Galapagos EUR 2.64B 104.07M Jun/2025
Genmab DKK 5.3B 6M Jun/2025
GlaxoSmithKline GBP 14.35B 197M Jun/2025
GRIFOLS EUR 7.6B 1.96B Jun/2025
Hikma Pharmaceutical USD 2.32B 35M Dec/2024
Inditex EUR 18.06B 1.62B Apr/2025
Merck EUR 28.26B 1.64B Jun/2025
Novartis USD 42.05B 3.6B Jun/2025
Philips EUR 10.38B 1.32B Jun/2025
Roche Holding CHF 36.16B 3.28B Dec/2024
Sanofi 70.28B 3.8B Jun/2025
Smith & Nephew USD 5.54B 271M Jun/2025
UCB EUR 10.03B 1.08B Dec/2024
Viscofan EUR 904.98M 36.96M Jun/2025